LLY · News · 20260829N

Market Demand - Anti-Obesity

ELI LILLY & Co · 2026-08-29 · Importance 10 · Surprise 6

Third-party reporting characterizes Eli Lilly’s revenue growth as massive and driven by high demand for its metabolic therapies. The report does not provide specific product-level, geographic, customer, or order-volume data. The commentary indicates continued strong market demand for Lilly’s metabolic-treatment portfolio relative to broader healthcare products.